The Adverse Events Following Immunisation Clinical Assessment Network (AEFI-CAN) is a collaboration between state and territory based vaccine safety/immunisation services, Commonwealth and jurisdictional health departments, and the Therapeutic Goods Administration (TGA). AEFI-CAN membership includes adult immunisation, paediatric immunisation, infectious disease, allergy and other specialists, as well as representatives from state and territory health departments, the Australian Government Department of Health and Aged Care and the TGA. AEFI-CAN currently has 55 active members.  

As a national network, AEFI-CAN works collaboratively to:

  • provide expert clinical evaluation and care of individuals who have experienced serious and/or unexpected AEFI
  • develop a consistent robust national approach to serious and/or severe AEFI, including the creation of standardised protocols
  • increase health/immunisation provider knowledge and practice about AEFI and vaccine safety
  • provide expert advice to health professionals, hospitals and health departments as required
  • participate in research on AEFI management and follow-up.
Last updated August 2022